Digest Network Come funziona
Network
/
Società
Ba
Non verificato

Bayer

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

157 comunicati stampa

Guarda tutti i comunicati
22/06/2026
Mercato del lavoro
Scienza
Farmaceutica
Salute
Tecnica
Medicina - Varie
Bayer and Iambic Collaborate to Advance Drug Discovery with AI
Fonte
Bayer
Emittente
Business Wire
1.00
0
18/06/2026
Bayer Welcomes Kacy Perry as New Country Division Head for Crop Science Canada
Fonte
Bayer
Emittente
Business Wire
1.00
0
17/06/2026
Legge/Diritto
Chimica
Associazioni/Professionisti
Industria
Sanità
Salute
Agricoltura
Materie prime
Federal Judge Remands Monsanto Class Settlement Case Back to MO State Court
Fonte
Bayer
Emittente
Business Wire
1.00
0
17/06/2026
Mercato azionario
Scienza
Salute
Medicina - Varie
Biotecnologia
Farmaceutica
Sanità
Ottica
Bayer Completes Acquisition of Perfuse Therapeutics
Fonte
Bayer
Emittente
Business Wire
1.00
0
16/06/2026
Aleve® Launches its Project DIY Campaign with HGTV Stars Dave & Jenny Marrs to Highlight Hardworking Hobbyists and Long-Lasting Pain Relief
Fonte
Bayer
Emittente
Business Wire
1.00
0
15/06/2026
Industria
Oncologia
Salute
Igiene alimentare
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions
Fonte
Bayer
Emittente
Business Wire
1.00
0
09/06/2026
Mercato del lavoro
Biotecnologia
Sanità
Salute
Medicina nucleare
Farmaceutica
Dr. Jost Reinhard Appointed President of Bayer’s Radiology Business
Fonte
Bayer
Emittente
Business Wire
1.00
0
08/06/2026
Mercato del lavoro
Sanità
Farmaceutica
Salute
Bayer Announces Global Consumer Health Leadership Changes to Accelerate Growth
Fonte
Bayer
Emittente
Business Wire
1.00
0
05/06/2026
Eventi
Industria
Scienza
Cardiologia
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Phase III FIND‑CKD Results Show Bayer’s KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non‑Diabetic Chronic Kidney Disease
Fonte
Bayer
Emittente
Business Wire
1.00
0
02/06/2026
Salute
Farmaceutica
Medicina - Varie
Cardiologia
Eventi
Bayer to Present First Full FIND-CKD Results Investigating KERENDIA® (finerenone) in Non-Diabetic Chronic Kidney Disease at ERA 2026
Fonte
Bayer
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0